Hyperprolactinaemia
- PMID: 17889620
- DOI: 10.1016/j.bpobgyn.2007.08.002
Hyperprolactinaemia
Abstract
Hyperprolactinaemia is a frequent cause of reproductive problems encountered in clinical practice. A variety of pathophysiological conditions can lead to hyperprolactinaemia; therefore, pregnancy, drug effects, hypothyroidism and polycystic ovary syndrome should be excluded before investigating for prolactin-secreting pituitary tumours. Prolactinomas are mainly diagnosed in women aged 20-40 years. They present with clinical features of hyperprolactinaemia (galactorrhoea, gonadal dysfunction), and more rarely with large tumours, headache and visual field loss due to optic chiasm compression. Medical therapy with dopamine agonists is the treatment of choice for both micro- and macroprolactinomas. Tumour shrinkage and restoration of gonadal function are achieved in the majority of cases with dopamine agonists. A trial of withdrawal of medical therapy may be considered in many patients with close follow-up. Pituitary surgery and radiotherapy currently have very limited indications. Pregnancies in patients with prolactinomas need careful planning and close monitoring.
Similar articles
-
Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia.N Engl J Med. 2003 Nov 20;349(21):2023-33. doi: 10.1056/NEJMoa022657. N Engl J Med. 2003. PMID: 14627787
-
Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up.Clin Endocrinol (Oxf). 2005 Oct;63(4):450-5. doi: 10.1111/j.1365-2265.2005.02364.x. Clin Endocrinol (Oxf). 2005. PMID: 16181238
-
Current treatment issues in female hyperprolactinaemia.Eur J Obstet Gynecol Reprod Biol. 2006 Apr 1;125(2):152-64. doi: 10.1016/j.ejogrb.2005.10.005. Epub 2005 Nov 9. Eur J Obstet Gynecol Reprod Biol. 2006. PMID: 16288952 Review.
-
Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma.Clin Endocrinol (Oxf). 2007 Jan;66(1):149-50. doi: 10.1111/j.1365-2265.2006.02686.x. Clin Endocrinol (Oxf). 2007. PMID: 17201816 No abstract available.
-
The management of hyperprolactinaemia.Br J Hosp Med. 1995 Apr 19-May 2;53(8):374-8. Br J Hosp Med. 1995. PMID: 7599897 Review.
Cited by
-
Cabergoline Failure and a Spontaneous Pregnancy in a Microprolactinoma with High Prolactin Levels.J Pers Med. 2022 Dec 14;12(12):2061. doi: 10.3390/jpm12122061. J Pers Med. 2022. PMID: 36556282 Free PMC article.
-
Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues.Clin Biochem Rev. 2018 Feb;39(1):3-16. Clin Biochem Rev. 2018. PMID: 30072818 Free PMC article. Review.
-
A 30-year-old woman with galactorrhea.CMAJ. 2020 Apr 14;192(15):E397-E398. doi: 10.1503/cmaj.190750. CMAJ. 2020. PMID: 32392501 Free PMC article. No abstract available.
-
Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism.J Clin Diagn Res. 2015 Jan;9(1):BC15-7. doi: 10.7860/JCDR/2015/9982.5443. Epub 2015 Jan 1. J Clin Diagn Res. 2015. PMID: 25737975 Free PMC article.
-
Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly.Eur Arch Psychiatry Clin Neurosci. 2020 Oct;270(7):901-910. doi: 10.1007/s00406-019-01090-1. Epub 2019 Dec 20. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31863164
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources